Literature DB >> 21290161

Fluctuating frontal lobe dysfunction in a patient with moyamoya disease.

Kee Ook Lee, Kyung-Yul Lee.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21290161     DOI: 10.1007/s10072-010-0474-3

Source DB:  PubMed          Journal:  Neurol Sci        ISSN: 1590-1874            Impact factor:   3.307


× No keyword cloud information.
  10 in total

1.  Neuropsychological and perfusion MR imaging correlates of revascularization in a case of moyamoya syndrome.

Authors:  A L Jefferson; G Glosser; J A Detre; G Sinson; D S Liebeskind
Journal:  AJNR Am J Neuroradiol       Date:  2006-01       Impact factor: 3.825

2.  Moyamoya disease in Washington State and California.

Authors:  Ken Uchino; S Claiborne Johnston; Kyra J Becker; David L Tirschwell
Journal:  Neurology       Date:  2005-09-27       Impact factor: 9.910

3.  Moyamoya disease--a review.

Authors:  J Suzuki; N Kodama
Journal:  Stroke       Date:  1983 Jan-Feb       Impact factor: 7.914

4.  Mental outcome following encephaloduroarteriosynangiosis in children with moyamoya disease with the onset earlier than 5 years of age.

Authors:  Y Matsushima; M Aoyagi; H Masaoka; R Suzuki; K Ohno
Journal:  Childs Nerv Syst       Date:  1990-12       Impact factor: 1.475

5.  [A case of moyamoya disease presenting with geographic mislocation, person misidentification and fantastic confabulation].

Authors:  R Hayashi; R Watanabe; M Mimura; M Kato; Y Katsumata
Journal:  No To Shinkei       Date:  2000-12

6.  Neural damage caused by cerebral hyperperfusion after arterial bypass surgery in a patient with moyamoya disease: case report.

Authors:  Kuniaki Ogasawara; Nobukazu Komoribayashi; Masakazu Kobayashi; Takeshi Fukuda; Takashi Inoue; Keiko Yamadate; Akira Ogawa
Journal:  Neurosurgery       Date:  2005-06       Impact factor: 4.654

Review 7.  Moyamoya disease and moyamoya syndrome.

Authors:  R Michael Scott; Edward R Smith
Journal:  N Engl J Med       Date:  2009-03-19       Impact factor: 91.245

8.  [Follow-up study on the relationship between age at onset of illness and outcome in patients with moyamoya disease].

Authors:  K Moritake; H Handa; Y Yonekawa; W Taki; T Okuno
Journal:  No Shinkei Geka       Date:  1986-07

9.  Effect of moyamoya disease on neuropsychological functioning in adults.

Authors:  Peter Karzmark; Penelope D Zeifert; Simon Tan; Leslie J Dorfman; Teresa E Bell-Stephens; Gary K Steinberg
Journal:  Neurosurgery       Date:  2008-05       Impact factor: 4.654

10.  Moyamoya disease in a patient with schizophrenia.

Authors:  Dan I Lubman; Christos Pantelis; Patricia Desmond; Tina-Marie Proffitt; Dennis Velakoulis
Journal:  J Int Neuropsychol Soc       Date:  2003-07       Impact factor: 2.892

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.